A personalized approach to obesity treatment may help breast cancer survivors improve their long-term health by identifying early which patients need more than behavioral and lifestyle interventions ...

Survivorship care should routinely address treatment toxicities plus bone and sexual health, physical function, and psychosocial support via dietitians, structured activity programs, and peer/affinity ...

For Dina Lorraine, going on the GLP-1 drug Zepbound in April of 2025 was a no-brainer. “I had no energy,” said the 58-year-old public relations professional from Auburn, Washington, who’s been treated ...

A sequential, response-adapted model used a 2‑month ≥5% loss threshold to decide continuation of behavioral therapy alone versus adding naltrexone/bupropion for insufficient responders. At six months, ...